Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite

PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study

By Karlsen Randi V.   Larsen Signe B.   Christensen Jane   Brasso Klaus   Friis Søren   Tjønneland Anne   Dalton Susanne Oksbjerg  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1609-1614

Informa Healthcare

Access to resources Recommend Favorite

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

By Barrou Benoît   Benoît Gérard   Ouldkaci Mahmoud   Cussenot Olivier   Salcedo Margarita   Agrawal Sudhanshu   Massicard Séverine   Bercovici Nadège   Ericson Mats   Thiounn Nicolas  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 453-460

Springer Publishing Company

Access to resources Recommend Favorite

Pre-clinical development of farnesyltransferase inhibitors

By Lobell R.B.   Kohl N.E.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 203-210

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer in Saskatchewan Canada, before and during the PSA era

By Skarsgard D.  

Cancer Causes and Control, Vol. 11, Iss. 1, 2000-01 ,pp. : 79-88

Springer Publishing Company

Access to resources Recommend Favorite